Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study
- 19 December 2007
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 23 (7) , 670-676
Abstract
Objective: To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment.Methods: Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. We evaluated whether, after 8 weeks of open antidepressant treatment, donepezil HCl (Aricept) would afford added cognitive benefit compared to placebo in a randomized 12‐week trial. A subsample continued in an 8‐month extension phase of open treatment with donepezil. Neuropsychological testing (NPT) was performed and antidepressant response monitored at baseline and the 8, 20, and 52‐week time points.Results: At 8‐weeks, the antidepressant response rate was 61% (14/23). Improvement in SRT immediate recall (SRT‐IR; e.g. episodic verbal memory) was observed in responders compared to non‐responders. During the 12‐week, placebo‐controlled, donepezil add‐on trial, patients on donepezil showed further improvement in SRT‐IR versus patients on placebo. In the open extension phase, patients who continued open donepezil treatment (n = 6) maintained improvement in memory and tended to show an advantage over patients who never received donepezil and were evaluated at the 52‐week time point (n = 6). There were no observed significant donepezil effects on non‐memory cognitive domains.Conclusion: These preliminary findings suggest that addition of a cholinesterase inhibitor (AChEI) following antidepressant medication treatment in elderly Dep‐CI patients may improve cognition, and support the need for a confirmatory, larger randomized placebo‐controlled trial. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Treatment of Vascular Dementia and Vascular Cognitive ImpairmentThe Neurologist, 2007
- A double‐blind, placebo‐controlled trial of memantine in age‐associated memory impairment (memantine in AAMI)International Journal of Geriatric Psychiatry, 2006
- Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesisNeurobiology of Aging, 2006
- Mild Cognitive Impairment: Where Are We?Alzheimer Disease & Associated Disorders, 2005
- Neuropsychological Differences Between Late-Onset and Recurrent Geriatric Major DepressionAmerican Journal of Psychiatry, 2005
- Quantitative and qualitative differences in the verbal learning performance of elderly depressives and healthy controlsJournal of the International Neuropsychological Society, 1998
- MRI and neuropsychological differences in early- and late-life-onset geriatric depressionNeurology, 1996
- Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressedPsychological Medicine, 1996
- Age of Onset and Medical Illness in Older Depressed InpatientsInternational Psychogeriatrics, 1995
- Depression and memory impairment: A meta-analysis of the association, its pattern, and specificity.Psychological Bulletin, 1995